Risk of Suicide After Cancer Diagnosis in England.
Adolescent
Adult
Aged
Aged, 80 and over
England
/ epidemiology
Esophageal Neoplasms
/ diagnosis
Female
Humans
Lung Neoplasms
/ diagnosis
Male
Mesothelioma
/ diagnosis
Middle Aged
Neoplasms
/ diagnosis
Pancreatic Neoplasms
/ diagnosis
Risk Factors
Stomach Neoplasms
/ diagnosis
Suicide
/ psychology
Young Adult
Journal
JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550
Informations de publication
Date de publication:
01 01 2019
01 01 2019
Historique:
pubmed:
27
11
2018
medline:
15
2
2020
entrez:
27
11
2018
Statut:
ppublish
Résumé
A diagnosis of cancer carries a substantial risk of psychological distress. There has not yet been a national population-based study in England of the risk of suicide after cancer diagnosis. To quantify suicide risk in patients with cancers in England and identify risk factors that may assist in needs-based psychological assessment. Population-based study using data from the National Cancer Registration and Analysis Service in England linked to death certification data of 4 722 099 individuals (22 million person-years at risk). Patients (aged 18-99 years) with cancer diagnosed from January 1, 1995, to December 31, 2015, with follow-up until August 31, 2017, were included. Diagnosis of malignant tumors, excluding nonmelanoma skin cancer. All deaths in patients that received a verdict of suicide or an open verdict at the inquest. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were calculated. Of the 4 722 099 patients with cancer, 50.3% were men and 49.7% were women. A total of 3 509 392 patients in the cohort (74.3%) were aged 60 years or older when the diagnosis was made. A total of 2491 patients (1719 men and 772 women) with cancer died by suicide, representing 0.08% of all deaths during the follow-up period. The overall SMR for suicide was 1.20 (95% CI, 1.16-1.25) and the AER per 10 000 person-years was 0.19 (95% CI, 0.15-0.23). The risk was highest among patients with mesothelioma, with a 4.51-fold risk corresponding to 4.20 extra deaths per 10 000 person-years. This risk was followed by pancreatic (3.89-fold), esophageal (2.65-fold), lung (2.57-fold), and stomach (2.20-fold) cancer. Suicide risk was highest in the first 6 months following cancer diagnosis (SMR, 2.74; 95% CI, 2.52-2.98). Despite low absolute numbers, the elevated risk of suicide in patients with certain cancers is a concern, representing potentially preventable deaths. The increased risk in the first 6 months after diagnosis may indicate an unmet need for psychological support. The findings of this study suggest a need for improved psychological support for all patients with cancer, and attention to modifiable risk factors, such as pain, particularly in specific cancer groups.
Identifiants
pubmed: 30476945
pii: 2714596
doi: 10.1001/jamapsychiatry.2018.3181
pmc: PMC6583458
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
51-60Subventions
Organisme : Medical Research Council
ID : G0802441
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L501487/1
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Références
J Behav Med. 2003 Jun;26(3):265-81
pubmed: 12845938
Psychooncology. 2012 Apr;21(4):351-6
pubmed: 21264989
BMJ. 2016 Sep 12;354:i4515
pubmed: 27618829
BMJ. 2011 Oct 05;343:d6030
pubmed: 21980064
IARC Sci Publ. 1987;(82):1-406
pubmed: 3329634
Int J Cancer. 2009 Jun 15;124(12):2917-22
pubmed: 19330831
Stat Med. 2004 Jan 15;23(1):51-64
pubmed: 14695639
Arch Gen Psychiatry. 2012 Mar;69(3):256-64
pubmed: 22393218
Scand J Public Health. 2005;33(3):208-14
pubmed: 16040462
Suicide Life Threat Behav. 2008 Dec;38(6):650-60
pubmed: 19152296
J R Soc Med. 2014 May;107(5):194-204
pubmed: 24526464
Psychol Med. 2006 Feb;36(2):145-57
pubmed: 16420711
J Clin Oncol. 2004 Oct 15;22(20):4209-16
pubmed: 15483032
BMJ. 2018 Apr 25;361:k1415
pubmed: 29695476
BMJ. 2017 Oct 17;359:j4627
pubmed: 29042363
Ann Oncol. 2007 Feb;18(2):381-7
pubmed: 17053045
Br J Cancer. 2009 Jul 7;101(1):198-201
pubmed: 19471277
Br J Clin Pharmacol. 2010 Jan;69(1):4-14
pubmed: 20078607
Lancet Oncol. 2011 Feb;12(2):160-74
pubmed: 21251875
Lancet Psychiatry. 2014 Oct;1(5):343-50
pubmed: 26360998
Br J Cancer. 2012 Sep 25;107(7):1195-202
pubmed: 22892390
Lancet Psychiatry. 2018 Apr;5(4):321-326
pubmed: 29544711
N Engl J Med. 2012 Apr 5;366(14):1310-8
pubmed: 22475594
Lancet Psychiatry. 2016 Jul;3(7):646-59
pubmed: 27289303
Cancer Nurs. 2012 Jul-Aug;35(4):E14-26
pubmed: 21946906
Pain. 2016 May;157(5):1079-84
pubmed: 26761386
Psychooncology. 2010 Dec;19(12):1250-8
pubmed: 20213857